Stock Scorecard



Stock Summary for Mckesson Corporation (MCK) - $831.92 as of 2/2/2026 8:31:50 AM EST

Total Score

15 out of 30

Safety Score

53 out of 100

Currently on the following lists
None
Tim's Recommendation
Possible Buy

Growth List Algorithm Criteria for MCK

Positive Quarterly and Annual earnings growth
P/E ratio less than Industry P/E Ratio
P/E ratio less than Sector P/E Ratio
P/E ratio that is half the Annual earnings growth rate (or less)
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Positive net income past year and 12 trailing months
Free cash flow ratio greater than 0 and less than 10

Small Cap List Algorithm Criteria for MCK

Revenue growing by at least 20% average per year over the last 5 years
Market Capitalization under 2 billion
Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months
Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months
Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year

Dividend List Algorithm Criteria for MCK

Declared an ex-dividend date
Forward annual dividend rate greater than 2
Positive net cash position the past year and most recent quarter
Equity to debt ratio greater than 0.75 for past year and most recent quarter
Current ratio most recent quarter greater than 2
Cash Flow per Share greater than Trailing Dividend Rate

Bonus Criteria for MCK

P/E ratio less than five-year Average P/E ratio
Last Price to 52 Week Low Ratio Less Than 1
Total Cash Per Share > Last Day Price
P/S Ratio < 1
P/B Ratio < 1

Safety Rating Criteria for MCK (53 out of 100)

Stock Price Rating (Max of 10) 10
Historical Stock Price Rating (Max of 10) 10
Stock Price Trend (Max of 10) 10
Book Value (Max of 10) 1
Book Value to Price (Max of 10) 0
Analyst Buy Ratings (Max of 5) 5
Analyst Strong Buy Ratings (Max of 5) 4
Dividend Yield Percentage (Max of 10) 1
Operating Margin (Max of 10) 0
Trading Volume (Max of 10) 6
Price to Earnings (Max of 10) 6
Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) 0

Latest News for for MCK

Principal Financial Group Inc. Has $215.36 Million Position in McKesson Corporation $MCK 2/2/2026 10:53:00 AM
The Truth About Cardinal Health Inc: Why Wall Street Suddenly Can’t Stop Talking 2/1/2026 9:25:00 AM
The Truth About Cardinal Health Inc: Why Wall Street Suddenly Can’t Stop Talking 2/1/2026 9:00:00 AM
Irving Giant McKesson Dumps Norway Pharmacies To Double Down On Cancer Care 1/31/2026 4:50:00 PM
Cencora’s Quiet Rally: Is The Drug-Distribution Giant Still A Buy After A Powerful Run? 1/31/2026 4:05:00 PM
Precision Trading with Mckesson Corporation (MCK) Risk Zones 1/31/2026 11:58:00 AM
Waystar Holding Taps EDB Postgres AI To Power Next‑Phase Growth 1/31/2026 10:29:00 AM
McKesson Corporation (NYSE:MCK) Receives Consensus Rating of "Moderate Buy" from Analysts 1/31/2026 9:44:00 AM
Lingohr Asset Management GmbH Acquires Shares of 6,266 McKesson Corporation $MCK 1/31/2026 9:30:00 AM
Federated Hermes Inc. Lowers Stock Holdings in McKesson Corporation $MCK 1/31/2026 9:30:00 AM

Financial Details for MCK

Company Overview

Ticker MCK
Company Name Mckesson Corporation
Country USA
Description McKesson Corporation (MCK) stands as a pivotal leader in the U.S. healthcare sector, excelling in the distribution of pharmaceuticals and medical supplies, as well as offering innovative healthcare management solutions. With a strong focus on leveraging advanced technology, McKesson enhances operational efficiencies for a wide array of healthcare stakeholders, including providers, payers, and pharmaceutical partners. The company’s commitment to innovation not only solidifies its competitive position but also drives improved patient outcomes and more effective healthcare delivery. As a vital player in the rapidly evolving healthcare landscape, McKesson is dedicated to promoting a more efficient, patient-centered approach to healthcare services.
Sector Name HEALTHCARE
Industry Name MEDICAL DISTRIBUTION
Most Recent Quarter 9/30/2025
Next Earnings Date 2/4/2026

Stock Price History

Last Day Price 831.92
Price 4 Years Ago 369.67
Last Day Price Updated 2/2/2026 8:31:50 AM EST
Last Day Volume 688,829
Average Daily Volume 562,438
52-Week High 894.75
52-Week Low 568.11
Last Price to 52 Week Low 46.44%

Valuation Measures

Trailing PE 25.91
Industry PE 24.69
Sector PE 188.49
5-Year Average PE 22.23
Free Cash Flow Ratio 24.99
Industry Free Cash Flow Ratio 44.39
Sector Free Cash Flow Ratio 30.14
Current Ratio Most Recent Quarter 0.88
Total Cash Per Share 33.29
Book Value Per Share Most Recent Quarter -14.02
Price to Book Ratio 5.04
Industry Price to Book Ratio 3.82
Sector Price to Book Ratio 57.14
Price to Sales Ratio Twelve Trailing Months 0.27
Industry Price to Sales Ratio Twelve Trailing Months 0.48
Sector Price to Sales Ratio Twelve Trailing Months 20.56
Analyst Buy Ratings 10
Analyst Strong Buy Ratings 3

Share Statistics

Total Shares Outstanding 123,427,000
Market Capitalization 102,681,389,840
Institutional Ownership 91.04%

Dividends

Ex-Dividend Date 3/2/2026
Previous Dividend Amount 0.8200
Current Dividend Amount 0.8200
Total Years Dividend Increasing Dividend Contender - Increasing for 18 Years
Trailing Annual Dividend Rate 3.06
Trailing Annual Dividend Yield 0.37%
Forward Annual Dividend Rate 3.28
Forward Annual Dividend Yield 0.40%
5-Year Dividend Payments Count 21
3-Year Average Dividend Yield 0.00%
5-Year Average Dividend Yield 0.00%
1-Year Dividend Growth Rate Percentage 7.19%
3-Year Dividend Growth Rate Percentage 3.53%
5-Year Dividend Growth Rate Percentage 12.88%
All-Time Dividend Growth Rate Percentage 4.05%
Dividend Payout Ratio 9.57%

Income Statement

Quarterly Earnings Growth YOY 377.00%
Annual Earnings Growth 9.76%
Reported EPS 12 Trailing Months 31.99
Reported EPS Past Year 18.12
Reported EPS Prior Year 33.10
Net Income Twelve Trailing Months 4,033,000,000
Net Income Past Year 3,295,000,000
Net Income Prior Year 3,002,000,000
Quarterly Revenue Growth YOY 10.10%
5-Year Revenue Growth 9.22%
Operating Margin Twelve Trailing Months 1.37%

Balance Sheet

Total Cash Most Recent Quarter 4,109,000,000
Total Cash Past Year 5,691,000,000
Total Cash Prior Year 4,583,000,000
Net Cash Position Most Recent Quarter -1,902,000,000
Net Cash Position Past Year 1,228,000,000
Long Term Debt Past Year 4,463,000,000
Long Term Debt Prior Year 5,579,000,000
Total Debt Most Recent Quarter 6,011,000,000
Equity to Debt Ratio Past Year -0.87
Equity to Debt Ratio Most Recent Quarter -0.41
Total Stockholder Equity Past Year -2,074,000,000
Total Stockholder Equity Prior Year -1,971,000,000
Total Stockholder Equity Most Recent Quarter -1,739,000,000

Free Cash Flow

Free Cash Flow Twelve Trailing Months 6,171,000,000
Free Cash Flow Per Share Twelve Trailing Months 50.00
Free Cash Flow Past Year 5,226,000,000
Free Cash Flow Prior Year 3,627,000,000

Options

Put/Call Ratio 1.99
Has Options Options Chain
Liquidity Rating

Technical Analysis

Yahoo Finance Chart Yahoo Finance Chart
MACD 0.00
MACD Signal 0.00
20-Day Bollinger Lower Band 0.00
20-Day Bollinger Middle Band 0.00
20-Day Bollinger Upper Band 0.00
Beta 0.41
RSI 0.00
50-Day SMA 0.00
150-Day SMA 0.00
200-Day SMA 514.55

System

Modified 1/31/2026 3:09:21 AM EST